These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37932927)

  • 1. A pilot study of orelabrutinib treatment in three cases of refractory/relapsed autoimmune haemolytic anaemia/Evans syndrome.
    Liu H; Ding K; Zhang W; Xing L; Wang Y; Wang H; Song J; Li L; Fu R
    Br J Haematol; 2024 Mar; 204(3):1082-1085. PubMed ID: 37932927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Outcomes of splenectomy in relapsed/refractory autoimmune hemolytic anemia].
    Fan SB; Wang ZJ; Mao Q; Tong CF; Zhai WT; Zheng YZ; Sun CX; Shi J
    Zhonghua Xue Ye Xue Za Zhi; 2019 Feb; 40(2):132-136. PubMed ID: 30831628
    [No Abstract]   [Full Text] [Related]  

  • 3. Sirolimus is effective for primary refractory/relapsed warm autoimmune haemolytic anaemia/Evans syndrome: a retrospective single-center study.
    Zhang Z; Hu Q; Yang C; Chen M; Han B
    Ann Med; 2023; 55(2):2282180. PubMed ID: 37967535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evans syndrome: a study of six cases with review of literature.
    Dhingra KK; Jain D; Mandal S; Khurana N; Singh T; Gupta N
    Hematology; 2008 Dec; 13(6):356-60. PubMed ID: 19055865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune haemolytic anaemia.
    Argüello Marina M; López Rubio M; Castilla García L
    Med Clin (Barc); 2023 Jan; 160(1):30-38. PubMed ID: 36334945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenence rituximab following induction in autoimmune cytopenias.
    Rai MP; Lee EJ; Bussel JB
    Br J Haematol; 2023 Jul; 202(1):153-158. PubMed ID: 37086173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ibrutinib treatment for 2 cases of relapsed/refractory autoimmune hemolytic anemia: a pilot study].
    Fang LW; Pan H; Shi J
    Zhonghua Xue Ye Xue Za Zhi; 2020 May; 41(5):412-416. PubMed ID: 32536139
    [No Abstract]   [Full Text] [Related]  

  • 8. Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia.
    Heidel F; Lipka DB; von Auer C; Huber C; Scharrer I; Hess G
    Thromb Haemost; 2007 Feb; 97(2):228-33. PubMed ID: 17264951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study.
    Deng LJ; Zhou KS; Liu LH; Zhang MZ; Li ZM; Ji CY; Xu W; Liu T; Xu B; Wang X; Gao SJ; Zhang HL; Hu Y; Li Y; Cheng Y; Yang HY; Cao JN; Zhu ZM; Hu JD; Zhang W; Jing HM; Ding KY; Zhang XY; Zhao RB; Zhang B; Tian YM; Song YP; Song YQ; Zhu J
    Blood Adv; 2023 Aug; 7(16):4349-4357. PubMed ID: 37078706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of Evans syndrome in adults: first consensus recommendations.
    Fattizzo B; Marchetti M; Michel M; Cantoni S; Frederiksen H; Giordano G; Glenthøj A; González-López TJ; Murakhovskaya I; Napolitano M; Mingot ME; Arguello M; Patriarca A; Raso S; Vianelli N; Barcellini W
    Lancet Haematol; 2024 Aug; 11(8):e617-e628. PubMed ID: 38968944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus is effective and safe in childhood relapsed-refractory autoimmune cytopenias: A multicentre study.
    Acar SO; Tahta N; Al IO; Erdem M; Gözmen S; Karapınar TH; Kılınç B; Celkan T; Kirkiz S; Koçak Ü; Ören H; Yıldırım AT; Arslantaş E; Ayhan AC; Oymak Y
    Scand J Immunol; 2024 Aug; 100(2):e13376. PubMed ID: 38741164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose intravenous immunoglobulin in the treatment of autoimmune haemolytic anaemia.
    Majer RV; Hyde RD
    Clin Lab Haematol; 1988; 10(4):391-5. PubMed ID: 3250787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study.
    Ducassou S; Leverger G; Fernandes H; Chambost H; Bertrand Y; Armari-Alla C; Nelken B; Monpoux F; Guitton C; Leblanc T; Fisher A; Lejars O; Jeziorski E; Fouissac F; Lutz P; Pasquet M; Pellier I; Piguet C; Vic P; Bayart S; Marie-Cardine A; Michel M; Perel Y; Aladjidi N
    Br J Haematol; 2017 Jun; 177(5):751-758. PubMed ID: 28444729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of metabolomics as a predictive guide for clinical management in autoimmunity against red blood cells.
    Kapur R
    Br J Haematol; 2023 Apr; 201(1):13-14. PubMed ID: 36597858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Evans syndrome.
    Norton A; Roberts I
    Br J Haematol; 2006 Jan; 132(2):125-37. PubMed ID: 16398647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric-onset Evans syndrome: Breaking away from refractory immune thrombocytopenia.
    Aladjidi N; Pincez T; Rieux-Laucat F; Nugent D
    Br J Haematol; 2023 Oct; 203(1):28-35. PubMed ID: 37735545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomic profile in patients with primary warm autoimmune haemolytic anaemia.
    Rabelo IB; Chiba AK; Moritz E; D'Amora P; Silva IDCG; Rodrigues CA; Barros MMO; Bordin JO
    Br J Haematol; 2023 Apr; 201(1):140-149. PubMed ID: 36484101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evans Syndrome and pregnancy: A case report with literature review.
    Parveen S; Mukhtar R; Shafee S; Mehmood R
    J Pak Med Assoc; 2019 Jul; 69(7):1047-1048. PubMed ID: 31983745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series.
    Yang C; Cui Y; Ren X; Li M; Yu K; Shen S; Jiang H; Li M; Zhang X; Zhao X; Zhu Q; Lin S
    Front Oncol; 2022; 12():901797. PubMed ID: 35785180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory/relapse thrombocytopenia in a patient with Evans' syndrome successfully treated with zanubrutinib.
    Li M; Liu L; Ding B; Song X; Xia A; Han Y; Song Y; Wei X; Zhou H
    Br J Haematol; 2022 Dec; 199(5):e37-e42. PubMed ID: 36223900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.